These results overall mechanistically demonstrate that iOPN represent a brake in TLR9-MYD88 signaling pathways in autoimmunity-driven B cell lymphomas, likely explaining why in OPN-deficient Faslpr/lpr mice the transformation of B cells occurs more frequently than in OPN-competent counterparts. This evidence concerns the gene MYD88 and B-cell non-Hodgkin lymphoma.